Sorafenib as a ferroptosis-related clinical drug has been approved by the United States Food and Drug Administration for the treatment of ovarian cancer (98)
Instead, it works by mimicking the glucagon-like peptide-1 (GLP-1) hormone, which targets areas of the brain that regulate appetite and food intake
Given the comprehensive role of NRF2 in stress response, inflammation, and bone metabolism, we thus hypothesized that NRF2 might be involved in the biological activity of SP
Who is at risk of developing black stools
Ozempic, cuyo compuesto se llama semaglutida, acta imitando al GLP-1, una hormona que regula el apetito y la saciedad, lo que puede llevar a comer menos y perder peso
Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY et al (2024) Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial